Riskpilot← Back to searchSign inGet full accessBIOSEARCH ApS
APSActiveCVR 20470984Tuborg Havnepark 2Activities of holding companies · NACE 6421Est. 1997— employees
Revenue 2024
DKK -18K
+7% vs 2023
EBITDA margin
100.0%
-7% vs 2023
Equity ratio
98.8%
Financial strength
Net profit 2024
DKK 2,6M
-24% vs 2023
| Revenue | DKK -18K | +7% |
| EBITDA | DKK -18K | -7% |
| Net profit | DKK 2,6M | -24% |
| Total assets | DKK 42,3M | +5% |
| Equity | DKK 41,8M | +6% |
| Employees | — | — |
Legal name
BIOSEARCH ApS
CVR number
20470984
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
1. november 1997
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er formueadministration.
Address
Tuborg Havnepark 2
Phone
+4540107500
Email
ak@kharazmi.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -23 | -14 | -17 | -15 | -14 | -14 | -14 | -14 | -17 | -14 | -14 | -17 | -18 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -23 | -14 | -17 | -15 | -14 | -14 | -14 | -14 | -17 | -14 | -14 | -17 | -18 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -23 | -14 | -17 | -15 | -14 | -14 | -14 | -14 | -17 | -14 | -14 | -17 | -18 |
| Net financials | 1.724 | 1.422 | 5.257 | -1.664 | 83 | 1.337 | 6.361 | 5.197 | 2.386 | 3.976 | -2.423 | 3.942 | 2.952 |
| Profit before tax | 1.701 | 1.408 | 5.239 | -1.680 | 68 | 1.322 | 6.346 | 5.183 | 2.369 | 3.961 | -2.437 | 3.925 | 2.934 |
| Tax | 9 | -0 | 7 | -0 | -0 | 6 | 3 | 341 | 338 | 303 | -162 | 485 | 335 |
| Net profit | 1.692 | 1.408 | 5.232 | -1.680 | 68 | 1.317 | 6.343 | 4.842 | 2.031 | 3.658 | -2.276 | 3.440 | 2.599 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 15.525 | 16.933 | 22.169 | 20.537 | 20.915 | 22.273 | 31.041 | 35.021 | 35.880 | 39.019 | 36.400 | 40.171 | 42.269 |
| Equity | 15.499 | 16.907 | 22.139 | 20.459 | 20.528 | 21.845 | 28.188 | 33.030 | 35.060 | 38.519 | 35.943 | 39.383 | 41.781 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 27 | 27 | 30 | 77 | 387 | 429 | 2.853 | 1.992 | 820 | 500 | 457 | 788 | 488 |
| Total debt | 27 | 27 | 30 | 77 | 387 | 429 | 2.853 | 1.992 | 820 | 500 | 457 | 788 | 488 |
EBITDA margin
-1812500.0%
This company
15.8%
Market median
-11471619% vs market
20122024
Equity ratio
98.8%
This company
38.2%
Market median
+159% vs market
20122024
Return on equity
6.2%
This company
18.4%
Market median
-66% vs market
20122024
Net profit margin
259852700.0%
This company
8.1%
Market median
+3208057925% vs market
20122024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PB Management | Management | 1997 | — | — |
SH Audit | Audit | 1998 | — | — |
HA Audit | Audit | 1997 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 1997 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIOSEARCH ApS 
LICA PHARMACEUTICALS A/SBoard members of BIOSEARCH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Preben Bang Henriksen | Management | 0 companies |
| Sven Halberg | Audit | 0 companies |
| Harry Aamann | Audit | 0 companies |